Comparative Head Lice Therapy With Dimet 5® vs. Hedrin® Once (VEKODIH)
Randomised, Investigator-blinded, Controlled, Multicentre Comparative Study on the Treatment of Head Lice Infestation With 2 Dimeticone Preparations With Different Application Times and Compositions: Dimet 5® (100% Dimeticon) Versus Hedrin® Once Liquid Gel (4% Dimeticon + Nerolidol)
Sponsor: Infectopharm Arzneimittel GmbH
This observational or N/A phase trial investigates Head Lice Infestation and Lice and is currently actively recruiting participants. Infectopharm Arzneimittel GmbH leads this study, which shows 8 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Recruiting
-
Sep 2024 — Sep 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Apr 2024 — Jul 2024 [monthly]
Recruiting
-
Dec 2023 — Apr 2024 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Apr 2023 — Dec 2023 [monthly]
Recruiting
-
Sep 2021 — Apr 2023 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jun 2021 — Sep 2021 [monthly]
Not Yet Recruiting
First recorded
May 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Infectopharm Arzneimittel GmbH
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aalen, Germany , Augsburg, Germany , Balingen, Germany , Berlin, Germany , Blankenfelde, Germany , Bremen, Germany , Chemnitz, Germany , Düsseldorf, Germany , Eschborn, Germany , Essen, Germany and 16 more locations